GB2072536A - Nebuliser - Google Patents
Nebuliser Download PDFInfo
- Publication number
- GB2072536A GB2072536A GB8109169A GB8109169A GB2072536A GB 2072536 A GB2072536 A GB 2072536A GB 8109169 A GB8109169 A GB 8109169A GB 8109169 A GB8109169 A GB 8109169A GB 2072536 A GB2072536 A GB 2072536A
- Authority
- GB
- United Kingdom
- Prior art keywords
- chamber
- medical
- nebulising
- rotatable member
- reservoir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
- A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nozzles (AREA)
Abstract
The apparatus is self-contained for carriage in a pocket or handbag and comprises a nebulising chamber 12 from which tangentially extends an outlet tube 14 leading to a perpendicular head 15 provided with a mouthpiece 16. The chamber is cylindrical and houses a rotatable disc 25. An adjustable air inlet 30 is provided in the chamber and material to be nebulised is introduced to the chamber 12 through the mouth 14c. The disc 25 is driven by a battery and electric motor in the casing 29 and both draws air in through the inlet 30 and breaks up the material in the casing to nebulise it. Baffles 40, 41 control the size of particles expelled and a damping connection 44 reducing unpleasantness to the user from vibrations. <IMAGE>
Description
SPECIFICATION
Medical nebulising apparatus
The present invention relates to medical nebu
lising apparatus for inhalatory use. In the
specification, the term "nebulisation" is in
tended to include the formation of a spray Wrom a power as well as from a liquid.
In the medical field, the inhalation of nebu
lised drugs is an accepted way of treating
various medical conditions such as asthma,
bronchitis, cystic fibrosis and other conditions
of the respiratory tract. Existing medical nebu
lisers are not easy to use by all patients. They
are expensive, bulky and require a separate
compressed air or oxygen supply, e.g. from a
compressed air container or from an electric
compressor device. A patient, therefore, is
unlikely to have or carry his own nebuliser
and has to visit a hospital for inhalation treat
ment.
It has been proposed to use a rotatable disc
for dispersing particles in a medical nebuliser.
The material is fed in an axial direction onto
the disc to disperse the particles in a large
chamber and an airstream is independently
generated to carry particles out of the cham
ber. There is generation of a large proportion
of large particles and the apparatus is mas
sive.
One common way of producing a spray is
the pressurised can, commonly used, for ex
ample, for such purposes as paint spraying,
air fresheners and insecticide sprays. Although
these cans are readily portable and are used
as inhalation devices, they suffer several
drawbacks. They require a pressurised carrier
gas, which itself is undersirable for environ
mental reasons and the pressure is excessively
high, with the result that the spray particles
impact in the mouth and coalsece. The de
vices are not re-usable and they need a very
high degree of co-ordination and effort by the
patient.
The present invention provides medical ne
bulising apparatus, comprising a housing in
cluding a chamber provided with a reservoir
for material to be nebulised, the housing
having an outlet portion for nebulised matetrial, a passage for nebulised material between
the chamber and the outlet portion, and nebu
lising means in the form of a driven rotatable member for effecting nebulisation, character
ised in that the rotatable member has its path
of rotation passing through the reservoir to
pick up material, the passage comunicates
with the chamber at a port radially spaced
from the path of rotation and positioned in the
path of particles flung from the rotatable
member and the chamber is shaped to direct
particles to the port in an air stream centrifu
gally generated by the rotatable member.
The rotatable element is preferably in the
form of a rotatable disc and the chamber preferably has a circular peripheral wall about the disc periphery. The passage from the chamber may be tangential to the chamber.
The air inlet is preferably an aperture in a wall of the chamber and a shutter may be provided to control the area of the inlet. It is preferred that a scale is provided to indicate the position of the shutter and, therefore, provide predetermined settings for the inlet area. The size of the inlet area determines the rate of delivery of nebulised material by controlling the rate of admission of air to the chamber during operation.
The passage between the chamber and the outlet portion preferably includes a baffle arrangement to assist in controlling the particle size at the outlet by returning larger particles to the chamber.
Apparatus according to the invention can be made sufficiently small for carrying in a pocket or handbag and can provide a fine mist with particles not exceeding 30y or even as low as 15y.
The use of a rotating wheel for flinging particles into a gas stream is a very old practice in some industries, for example, for comminuting metals and electrostatic powder coating. These industrial processes are described in the following U.K. patent specifications, which have been located by searching, since the invention was made.
U.K. Patent No. 1,173,380 describes an apparatus for developing electrostatic charge images which involves the use of a disc electrode in an enclosed chamber which dips, while revolving, in a dye liquid. A high voltage is applied to the electrode to cause atomization of the dye liquid and the atomised particles migrate, by virtue of an applied electrical field, to a conductive support for a recording material carrying a charge image.
U.K. Patent No. 1,085,092 describes an apparatus which uses a rotating toothed-disc to direct liquid particles from a reservoir into a gas stream. This apparatus essentially requires a separate supply of gas under pressure to enable the apparatus to function.
An. apparatus for comminuting molten metal for the purpose of, for example, producing an oxide of that metal is described in U.K. Patent
No. 519,784, and a very similar apparatus is described in U.K. Patent No. 574,385. The apparatus of each of these specifications requires a vessel for containing a mass of molten metal and a rotating wheel flings the particles of the molten metal into a gas stream. Specification No. 519,784, which was published forty years ago, does fleetingly, in one sentence, consider that the rotating wheel might serve to produce the gas stream, but for these industrial processes, as for present day medical nebulisers, it is accepted that a separate gas stream-producing apparatus is essential.
Reference is now made to the accompany ing drawings, wherein:~
Figure 1 is a perspective view of a first embodiment of a medical nebulising apparatus according to the invention;
Figure 2 is a perspective view of a broken away portion of the apparatus of Fig. 1 showing a reservoir thereof;
Figure 3 is a sectional side elevation on the line 3-3 of Fig. 1:
Figure 4 is a sectional view on the line 4-4 of Fig. 1;
Figures 5 and 6 are sectional views similar to Figs. 3 and 4 of a second embodiment; and
Figures 7 and 8 are sectional views similar to Figs. 3 and 4 of a third embodiment.
Referring to Figs. 1 to 4, there is shown a medical nebulising apparatus comprising a housing 11 having a hollow cylindrical portion 12 having a chamber 13 therein. An outlet tube 14 leads upwardly (in the position of use shown in Fig. 1) from the cylindrical portion to define an outlet passage tangential to the chamber 13 and communicating therewith through a port 13a. The outlet tube 14 leads to a tubular head 15, which has a T connection with the tube 14. A mouthpiece 16 is connected to one end of the head 15. In use, material to be nebulised is contained in the chamber 12 and a fine spray consisting of an air stream entraining particles of the material is provided at the mouthpiece, as described hereafter.
The lower portion of the chamber 13 opposite to the tube 14 defines a reservoir 18 and internal sloping surfaces 19, 20 cause the reservoir to narrow towards the periphery, each sloping surface being arcuate and following the internal peripheral contour of the chamber as is apparent from Fig. 2. Each surface is defined in this construction by a solid internal wall 21. 22 of substantially triangular section as is apparent from Fig. 4.
A nebulising disc 25 is rotatably mounted in the chamber 13 by an axle 26, so that part of the marginal periphery of the disc lies between the sloping surfaces 19. 20 in the reservoir, the diameter of the disc being only slightly less than that of the container and the general plane of the disc being parallel to the side walls 12a, 1 2b of the cylindrical portion 12. The axle is driven by an electrical motor 27 and a replaceable electric battery 28 mounted in a casing 29 on one side wall 12a of the cylindrical portion 12. which defines the chamber 13. A switch 28a is accessible externally of the casing and is actuable to operate the moter.
The opposite side wall 12b of this portion has a central air inlet 30, the size of which is variable by means of a shutter 31. The shutter in this embodiment is in the form of a disc pivotally mounted by pivot pin 32 on the side wall 12b. The shutter has an aperture 33 of equal diameter to the inlet 30, so that the inlet is fully open with the aperture 33 and the inlet in register. The shutter can be angularly moved to reduce the area of the inlet exposed. The shutter carries a pointer 35 associated with an arcuate scale 36 marked on the side wall 1 2b, so that a predetermined area of the inlet can be exposed recording the scale reading.
The outlet parts of the device have an internal baffle arrangement defined by a constriction 40 near the mouth of the outlet tube 14, adjacent the head 15. and a conical projection 41 provided in the head 15 directly opposite the outlet tube 14, the apex 42 of the projection 41 being on the axis of the outlet tube. The end of the head opposite to the mouthpiece 16 is closed except for a vent 43. A flexible bellows 44 attaches the mouthpiece 16 to the head 15.
The outlet tube 14 comprises an upper part 1 4a, integral with the head 15 and a lower part 1 4b, integral with the cylindrical portion 12. The upper and lower parts are push-fitted together. The head 15, with the upper part 14a, can, therefore, be removed, so that the mouth 1 4c of the lower part defines an inlet.
In use, the material to be nebulised is introduced to the reservoir 18 through the inlet mouth 14c. The patient's mouth is put to the mouthpiece 16 and the electric motor is energised by operating the switch 28a. The nebulising disc 25 is thereby rotated in the direction of arrow B in Fig. 3. A part of the periphery is immersed in the material in the reservoir 18. so that the disc flings particles of the material along the tangential passage in the outlet tube 14. The rotating disc also serves as a centrifugal pump to draw air in through the inlet 30 and produce a gas stream along the passage in the outlet tube, the particles of the material being entrained in the gas stream so that nebulised material passes out of the mouthpiece 16 in a fine spray. The amount of air drawn into the chamber can be controlled by the position of the shutter 31.
As the disc flings particles of the material at a high speed, these particles (especially the larger ones) tend to impact against the inner walls of the chamber 13 and shatter into even smaller particles. The larger particles entering the tube 14 tend to coalesce and drip back into the reservoir 18 or onto the disc for further treatment. This continuous and repeated action leads to the generation of very small particles. The constriction 40 obstructs flow of larger particles and assists this action as does the conical projection 41 which serves to direct particles which coalesce there back into the reservoir. The spray at the mouthpiece may therefore be made up of particles of maximum size of 15,u.
The vent permits sucking in of extra air by a patient and also prevents a sucking action at the mouthpiece from drawing in material from
the reservoir and relieves pressure, if the
patient obstructs the mouthpiece or blows
back into the mouthpiece. The patient can
breathe freely, therefore, without interfering
with the operation of the apparatus. Venting
in this case also prevents wetting of the
material in the reservoir from the user's ##breath, which is important, if the material is a powder.
The shaping of the reservoir 18 minimises
changes in the depth of material therein, with
changes in orientation of the apparatus.
The disc may be rotationally mounted off
centre or may be unbalanced about the axis
by other means such as weighting to cause
vibrations, which assist in breaking up and
fluidising the material in the reservoir to im
prove nebulisation. This may be especially
useful where the material is a powder. Large
particles incapable of being nebulised in the
apparatus could be contained in the reservoir
to cause such vibration and assist in breaking
the powder particles into even smaller ones.
These vibrations could cause unpleasant
sensations in the lips of the user and the
flexible bellows 44 serves to damp the vibra
tions at the mouthpiece.
The disc is preferably rotated at 8000
r.p.m. or more to provide a good rate of
delivery of nebulised material.
The described nebulising apparatus is small
and is capable of being held in a pocket or
handbag. This is assisted by the connection
between the tube parts 14a, 14b, which
permits swivelling of the parts to make the
apparatus more compact.
The motor casing 29 may be removable to
facilitate sterilisation, unless the casing is wa
tertight. The casing may have, for example, a
bayonet or screw fitting with the cylindrical
portion 12 and the shaft 26 may have two
parts with a spline connection. The battery
may be recharageable from the mains.
An alternative embodiment is shown in
Figs. 5 and 6, in which the overall construc
tion is substantially the same as the embodi
ment described above. In this case there are
two parallel closely spaced nebulising discs
and the internal walls of the reservoir 11 8 are
further spaced at the periphery of the cham rber 114 to accommodate the two discs. In
this case the walls 119, 120 are convexly
curved in section instead of straight.
Instead of the projection 41 and constric
tion 40, baffles 140, 141 are provided in the
head 115. Ventilation holes 150 are option
ally provided in this case adjacent to the
mouthpiece 116, the sizing being adjustable
by relative movement of the mouthpiece 116
and the rest of the head 115.
Figs. 7 and 8 show a modification of the
embodiment of Figs. 5 and 6, in which the
nebulising discs are eccentrically positioned
relative to the peripheral wall of the chamber
and are of smaller diameter than in the previously described embodiment. The discs can be rotated in either direction. The discs are positioned near the bottom of the chamber to extend into the reservoir 218, as previously.
In this case, a radial baffle 260 is provided in the chamber extending towards the discs. This enhances agitation and disruption of particles within the chamber as a result of impact and also redirects larger particles onto the discs for further treatment.
The mouthpiece 216, in this case is mounted in the outlet from the head 215 by means of a resilient bung 244 to absorb vibrations. An outlet nozzle 245 extends through the bung to communicate the interior of the mouthpiece with the interior of the head. Ventilation holes 250 are provided around the mouthpiece. This arrangement is preferred and is particularly effective to permit the user to breathe freely and to prevent air from the lungs of the user reaching the reservoir.
Each of the described embodiments can be easily cleaned and sterilised.
A very simple arrangement may be effective where the head, such as 15 in Fig. 1, is not provided, but the outlet tube 14 itself may define the mouthpiece. The inlet for air may be defined by the outlet tube, the latter being sufficiently wide to permit sucking of air into the chamber. In this case, a mouthpiece may be provided having an inner outlet tube surrounded by venting, as shown in Fig. 7.
It is envisaged that a nebuliser may be constructed according to the invention for use in an incubator.
The nebuliser may also be usable in nonmedical fields, for eample, for providing a fine spray in a greenhouse for dispersing an insecticide.
Claims (15)
1. Medical nebulising apparatus, comprising a housing including a chamber provided with a reservoir for material to be nebulised and having an air inlet, the housing having an outlet portion for nebulised material and a passage for nebulised material between the chamber and the outlet portion, and nebulising means in the form of a driven rotatable member for effecting nebulisation, the rotatable member having its path of rotation passing through the reservoir to pick up material, the passage communicating with the chamber at a port radially spaced from the path of rotation and positioned in the path of particles flung from the rotatable member, and the chamber being shaped to direct particles to the port in an air stream centrifugally generated by the rotatable member.
2. Medical nebulising apparatus according to Claim 1, wherein the rotatable member is a disc pivotally mounted approximately at its centre and the chamber has a generally circular section generally perpendicular to the axis of rotation of the rotatable member.
3. Medical nebulising apparatus according to Claim 2, wherein the rotatable member comprises a pair of closely spaced generally parallel discs mounted on a common axis of rotation.
4. Medical nebulising apparatus according to Claim 2 or 3, wherein the reservoir is defined by a narrowed portion of the chamber opposite to the port, which is in the peripheral wall of the chamber, and the passage joining the chamber tangentially.
5. Medical nebulising apparatus according to any preceding Claim, wherein the air inlet is in a wall of the chamber and its effective area is selectively variable.
6. Medical nebulising apparatus according to Claim 5, comprising a shutter, the wall of the chamber and the shutter being provided one with a pointer and the other with a scale for indicating selectable positions of the shutter.
7. Medical nebulising apparatus according to any preceding Claim, wherein the rotatable element is unbalanced to produce vibrations in the reservoir.
8. Medical nebulising apparatus according to any preceding Claim including particles in the reservoir incapable of nebulisation in the apparatus to assist break up of material where the latter is powder.
9. Medical nebulising apparatus according to any preceding Claim including a baffle arrangement to assist return of larger particles to the chamber, so as to control the size of particles of material in the air stream to a maximum of 30,t.
10. Medical nebulising apparatus according to any preceding Claim, wherein the passage is defined by a first portion leading from the chamber and a second portion generally perpendicular thereto and leading to the outlet portion.
11. Medical nebulising apparatus according to Claim 10, wherein the first portion is in two separable parts to permit filling of the reservoir through said port.
12. Medical nebulising apparatus according to Claim 10 or 11, including one or more vents in the second portion or in the outlet portion.
13. Medical nebulising apparatus according to any preceding Claim including an electric motor for driving the rotatable member and holding means for holding an electrical storage cell for operating the motor.
14. Medical nebulising apparatus accord
ing to Claim 13. wherein the motor and said
holding means are provided in a casing deta
chable from the housing, and a splittable shaft
between the electric motor and the rotatable
member.
15. Medical nebulising apparatus con
structed substantially as herein described with
reference to Figs. 1 to 4, or Figs. 5 and 6, or
Figs. 7 and 8 of the accompanying drawings
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8109169A GB2072536B (en) | 1980-03-25 | 1981-03-24 | Nebuliser |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8010010 | 1980-03-25 | ||
GB8109169A GB2072536B (en) | 1980-03-25 | 1981-03-24 | Nebuliser |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2072536A true GB2072536A (en) | 1981-10-07 |
GB2072536B GB2072536B (en) | 1983-12-07 |
Family
ID=26274957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8109169A Expired GB2072536B (en) | 1980-03-25 | 1981-03-24 | Nebuliser |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2072536B (en) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2275877A (en) * | 1993-03-06 | 1994-09-14 | Stephen James Rowland | Centrifugal atomisation of liquids |
WO1997026934A2 (en) * | 1996-01-25 | 1997-07-31 | Abrams Andrew L | Inhalation device |
US6142146A (en) * | 1998-06-12 | 2000-11-07 | Microdose Technologies, Inc. | Inhalation device |
US6152130A (en) * | 1998-06-12 | 2000-11-28 | Microdose Technologies, Inc. | Inhalation device with acoustic control |
WO2001007107A2 (en) * | 1999-07-23 | 2001-02-01 | Pharmaceutical Discovery Corporation | Unit dose capsules and dry powder inhaler |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US9192675B2 (en) | 2008-06-13 | 2015-11-24 | Mankind Corporation | Dry powder inhaler and system for drug delivery |
US9220687B2 (en) | 2008-12-29 | 2015-12-29 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9233159B2 (en) | 2011-10-24 | 2016-01-12 | Mannkind Corporation | Methods and compositions for treating pain |
US9241903B2 (en) | 2006-02-22 | 2016-01-26 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US9346766B2 (en) | 2004-08-20 | 2016-05-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US9662461B2 (en) | 2008-06-13 | 2017-05-30 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9801925B2 (en) | 1999-06-29 | 2017-10-31 | Mannkind Corporation | Potentiation of glucose elimination |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US9943571B2 (en) | 2008-08-11 | 2018-04-17 | Mannkind Corporation | Use of ultrarapid acting insulin |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10342938B2 (en) | 2008-06-13 | 2019-07-09 | Mannkind Corporation | Dry powder drug delivery system |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
-
1981
- 1981-03-24 GB GB8109169A patent/GB2072536B/en not_active Expired
Cited By (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2275877B (en) * | 1993-03-06 | 1996-11-27 | Stephen James Rowland | Atomisation of liquids |
GB2275877A (en) * | 1993-03-06 | 1994-09-14 | Stephen James Rowland | Centrifugal atomisation of liquids |
EP1563864A3 (en) * | 1996-01-25 | 2010-11-17 | MicroDose Therapeutx, Inc. | Inhalation device |
WO1997026934A2 (en) * | 1996-01-25 | 1997-07-31 | Abrams Andrew L | Inhalation device |
WO1997026934A3 (en) * | 1996-01-25 | 1997-09-25 | Andrew L Abrams | Inhalation device |
US6026809A (en) * | 1996-01-25 | 2000-02-22 | Microdose Technologies, Inc. | Inhalation device |
EP1563864A2 (en) * | 1996-01-25 | 2005-08-17 | Microdose Technologies Inc. | Inhalation device |
US6142146A (en) * | 1998-06-12 | 2000-11-07 | Microdose Technologies, Inc. | Inhalation device |
US6152130A (en) * | 1998-06-12 | 2000-11-28 | Microdose Technologies, Inc. | Inhalation device with acoustic control |
US9801925B2 (en) | 1999-06-29 | 2017-10-31 | Mannkind Corporation | Potentiation of glucose elimination |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US8146588B2 (en) | 1999-07-23 | 2012-04-03 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US8156936B2 (en) | 1999-07-23 | 2012-04-17 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US8215300B2 (en) | 1999-07-23 | 2012-07-10 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
WO2001007107A3 (en) * | 1999-07-23 | 2001-06-21 | Pharmaceutical Discovery Corp | Unit dose capsules and dry powder inhaler |
WO2001007107A2 (en) * | 1999-07-23 | 2001-02-01 | Pharmaceutical Discovery Corporation | Unit dose capsules and dry powder inhaler |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
US9346766B2 (en) | 2004-08-20 | 2016-05-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9796688B2 (en) | 2004-08-20 | 2017-10-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US10130685B2 (en) | 2004-08-23 | 2018-11-20 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US10143655B2 (en) | 2005-09-14 | 2018-12-04 | Mannkind Corporation | Method of drug formulation |
US9446001B2 (en) | 2005-09-14 | 2016-09-20 | Mannkind Corporation | Increasing drug affinity for crystalline microparticle surfaces |
US9717689B2 (en) | 2005-09-14 | 2017-08-01 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US9241903B2 (en) | 2006-02-22 | 2016-01-26 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US10130581B2 (en) | 2006-02-22 | 2018-11-20 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US9511198B2 (en) | 2008-06-13 | 2016-12-06 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10751488B2 (en) | 2008-06-13 | 2020-08-25 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9192675B2 (en) | 2008-06-13 | 2015-11-24 | Mankind Corporation | Dry powder inhaler and system for drug delivery |
US9662461B2 (en) | 2008-06-13 | 2017-05-30 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9339615B2 (en) | 2008-06-13 | 2016-05-17 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10342938B2 (en) | 2008-06-13 | 2019-07-09 | Mannkind Corporation | Dry powder drug delivery system |
US9446133B2 (en) | 2008-06-13 | 2016-09-20 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10201672B2 (en) | 2008-06-13 | 2019-02-12 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US10675421B2 (en) | 2008-06-20 | 2020-06-09 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9943571B2 (en) | 2008-08-11 | 2018-04-17 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10172850B2 (en) | 2008-12-29 | 2019-01-08 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9220687B2 (en) | 2008-12-29 | 2015-12-29 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9655850B2 (en) | 2008-12-29 | 2017-05-23 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US10130709B2 (en) | 2011-06-17 | 2018-11-20 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9233159B2 (en) | 2011-10-24 | 2016-01-12 | Mannkind Corporation | Methods and compositions for treating pain |
US10258664B2 (en) | 2011-10-24 | 2019-04-16 | Mannkind Corporation | Methods and compositions for treating pain |
US9610351B2 (en) | 2011-10-24 | 2017-04-04 | Mannkind Corporation | Methods and compositions for treating pain |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Also Published As
Publication number | Publication date |
---|---|
GB2072536B (en) | 1983-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4452239A (en) | Medical nebulizing apparatus | |
GB2072536A (en) | Nebuliser | |
ES2960295T3 (en) | Smoking substitute device comprising multiple aerosols and passive aerosol generation | |
US3812853A (en) | Apparatus for applying medication or the like to human nasal passages | |
US5170782A (en) | Medicament nebulizer with improved aerosol chamber | |
JP2912453B2 (en) | Dry powder inhaler | |
EP0640354B1 (en) | Whirl chamber powder inhaler | |
AU2006244478B2 (en) | Ultrasonic aerosol generator | |
US6748944B1 (en) | Ultrasonic dosage device and method | |
JP2005503238A (en) | Respiratory ultrasonic nebulizer and ampoule for exclusive use | |
JPH08103499A (en) | Inhalation type medicine administrator | |
ATE132378T1 (en) | HAND-HELD NEBULIZER FOR ATOMIZING THERAPEUTIC LIQUIDS | |
WO1994020163A1 (en) | Atomisation of liquids | |
US20190054260A1 (en) | Nebulizer devices and methods | |
EP0048244B1 (en) | Medical nebulising apparatus | |
JP2004501718A (en) | Aerosol inhalation interface | |
JPH05192418A (en) | Negative ion air generator | |
CN209173130U (en) | A kind of medical mask formula atomizer | |
EP0213056B1 (en) | Method and apparatus for producing a stream of heated vapor particularly useful for therapeutic purposes | |
US2847248A (en) | Nebulizer | |
JP3035643B2 (en) | Inhaler | |
CN112237666B (en) | Atomizer and sublingual nozzle for atomizer | |
SU1676631A1 (en) | Inhaler | |
JPH06154329A (en) | Air cleaner | |
GB2603109A (en) | Nebuliser mouthpiece |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19960324 |